Use access key #2 to skip to page content.
$5.25 -0.37 (-6.58%)
12/4/2008 4:00 PM

Idenix Pharmaceuticals, Inc. (IDIX)

CAPS Rating:
*

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

View All Commentary (IDIX)

Recs

1

Avatar tenmiles (99.99) Submitted: 1/09/08 12:40 PM : Underperform Start Price: $3.24 IDIX Score: -100.69

Forget Novartis, use today's strength to short Idenix at $3.25; techncially well overbought - looking for 15% pullback within two quarters.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links